Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide is an investigational triple agonist peptide that targets three key metabolic receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Mortality in HICs has declined significantly over the past two decades, with current estimates between 1520%, yet the economic burden remains substantial, with per-patient costs ranging from $20,000 to $50,000 (2, 3)
Patients experiencing episodic right upper quadrant discomfort, particularly after meals, should contact their healthcare provider within 24-48 hours
Use a food tracking app for the first few weeks to ensure you are meeting protein targets even as overall calories drop
US$ 24.16
US$ 22.60
US$ 28.91
US$ 23.24
US$ 23.24
US$ 24.34
